<DOC>
	<DOCNO>NCT01936376</DOCNO>
	<brief_summary>The project design test new biomarkers sensitive current standard detect injury proximal kidney tubule establish good criterion kidney safety concern may halt test drug human .</brief_summary>
	<brief_title>A Prospective Observational Study Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle Cisplatin Chemotherapy Head Neck Cancers</brief_title>
	<detailed_description>The study conduct four major medical center , include University Southern California , University Minnesota , Dana Farber Cancer Institute , MD Anderson Cancer Center . Blood urine sample collect patient undergo treatment either cisplatin aminoglycosides , two different drug know cause injury proximal tubule kidney . Cisplatin common chemotherapy drug take patient head neck cancer . Aminoglycosides common antibiotic drug take patient cystic fibrosis .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Inclusion Criteria ( Cisplatin Treatment Group ) : 1 . Males females ≥ 18 year age 2 . Diagnosis head &amp; neck cancer confirmation patient due receive 1st cycle cisplatin ( 75100 mg/m2/cycle ) chemotherapy either : single agent chemotherapy conjunction local radiotherapy course , part TPF combination ( docetaxel , cisplatin , fluorouracil ) 3 . Willingness ability comply study procedure study restriction 4 . Ability provide write informed consent Inclusion Criteria ( Control Group ) : 1 . Males females ≥ 18 year age 2 . Diagnosis head &amp; neck cancer similar condition upper body , localised malignancy . These control patient schedule receive nonnephrotoxic treatment modality ( e.g . local radiotherapy alone ) 3 . Willingness ability comply study procedure study restriction 4 . Ability provide write informed consent Exclusion Criteria ( All Subjects ) : 1 . Chronic kidney disease define eGFR &lt; 60 mL/min/1.73m2 . Patients normal eGFR persistent dipstick proteinuria require urinary albumin measurement : microalbuminuria ( &gt; 30 mcg/mg creatinine ) exclude 2 . Patients currently receive potentially nephrotoxic agent ( i.e . chronic use high dose NSAIDs , intravenous aminoglycosides , intravenous colistin , intravenous vancomycin , ACEi ) 3 . Any major surgery ( i.e . high risk acute kidney injury ) previous month 4 . Patients currently receive trimethoprim cimetidine medication know alter tubular secretion creatinine 5 . Use creatine supplement within 7 day prior hospitalization 6 . Solid organ transplant recipient 7 . Abnormal liver function ( serum ALT , AST total bilirubin &gt; 2xULN ) 8 . Significant anemia ( Hemoglobin &lt; 10 g/dL ) 9 . Pregnancy 10 . Institutionalized individual</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>kidney safety</keyword>
	<keyword>biomarkers</keyword>
	<keyword>serum creatinine</keyword>
	<keyword>BUN</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>renal injury</keyword>
	<keyword>drug induce acute kidney injury</keyword>
	<keyword>aminoglycoside</keyword>
	<keyword>cisplatin</keyword>
	<keyword>nephrotoxicity</keyword>
	<keyword>biomarker qualification</keyword>
</DOC>